Abstract
In humans, the defective invasion of the maternal endometrium by fetal extravillous trophoblasts (EVTs) can lead to insufficient perfusion of the placenta, resulting in pregnancy complications that can put both mother and baby at risk. To study the invasion of maternal endometrium between (W)5.5–12 weeks of gestation by EVTs, we combined fluorescence in situ hybridization, immunofluorescence and immunohistochemistry to determine the presence of (male) EVTs in the vasculature of the maternal decidua. We observed that interstitial mononuclear EVTs directly entered decidual veins and lymphatics from W5.5. This invasion of decidual veins and lymphatics occurred long before endovascular EVTs remodelled decidual spiral arteries. This unexpected early entrance of interstitial mononuclear EVTs in the maternal circulation does not seem to contribute to the materno-placental vascular connection directly, but rather to establish (and expand) the materno-fetal interface through an alternative vascular route.
Introduction
During human placental development, at the tips of the anchoring villi, cytotrophoblasts proliferate into cell columns and from there they can detach and invade the maternal decidualized endometrium (decidua) and even the myometrium [1, 2]. Those invading fetal cytotrophoblasts are known as extravillous trophoblasts (EVTs).
At term, there are several subtypes of EVTs present in the maternal decidua, depending on their localization: the interstitial mononuclear (as well as multinuclear) EVTs are dispersed in the decidual mesenchyme; the endovascular EVTs and intramural EVTs are both directly associated with remodeled spiral arteries and are present in their lumen (or replacing the endothelial cells) and in their tunica media [3] respectively and those EVTs migrate-colonize the spiral arteries in a retrograde fashion [4]; and a fourth category of ‘epithelial’ EVTs lines, together with maternal endothelial cells in a mosaic fashion, the basal plate of the maternal decidua basalis [5].
In humans, the defective invasion of the maternal decidua by fetal EVTs leads to insufficient perfusion of the placenta, resulting in pregnancy complications, such as intrauterine growth restriction, (recurrent) spontaneous abortion, (very) premature birth and preeclampsia [6, 7]. The unique vascular remodeling of the maternal decidua during pregnancy, whereby both fetal and maternal cells play complementary regulatory roles, is a fundamental process for a successful pregnancy [8, 9].
Endovascular EVTs are observed in spiral arteries from (W)8 weeks of gestation, ‘plugging’ (or blocking) the entrance of spiral arteries to the intervillous space preventing maternal blood flow until about W12 [10–12]. During this period (W8-W12), decidual veins become dilated in both decidua parietalis and basalis to give rise to decidual venous lakes [13]. By W12, both decidual veins and spiral arteries are in open connection with the intervillous space of the placenta allowing the maternal blood to circulate between the placental villi [10–12]. This materno-placental vascular connection provides efficient exchange of nutrients, waste products, hormones and gases between the maternal blood and the fetal blood and is crucial to ensure fetal growth.
After the materno-placental vascular connection is established, the constant maternal blood flow transports small tissue fragments (syncytial knots) that are shed from the outer layer of the placental villi of multinucleated (non-viable) syncytiotrophoblasts into the decidual venous where those knots become trapped and are subsequently cleared [13–15]. If the syncytial knots escape to enter the maternal circulation, they can cause trophoblastic embolism and even sudden death of the mother [16].
Interestingly, the presence of fetal cells [17], placental-derived particles and exosomes [18, 19] in the maternal blood from W6 has been described, but in the absence of robust materno-placental vascular connection this remains to be clarified. Therefore, we sought to systematically characterize the presence of EVTs in the endometrium in the period W5.5-W12. Our results indicate that between W5.5-W12, interstitial mononuclear EVTs efficiently enter the maternal (blood and lymph) circulation. This novel aspect of EVT invasion, enlarging materno-fetal interface early during pregnancy, may shed new light in our understanding of pregnancy complications and maternal immune tolerance.
Materials and Methods
Ethics approval and human tissue collection
The Medical Ethics Committee of the Leiden University Medical Center (protocol P08.087) approved the collection and use of material for this study. Written informed consent was obtained from all patients (N = 13). Tissue was obtained by vacuum aspiration from women undergoing voluntary pregnancy termination without medical indication and obtained anonymized. The gestational age (in weeks and days) was determined by obstetric ultrasonography and can be converted to weeks post conception by subtracting two weeks. Tissue samples (S1 Table) were collected in cold saline solution (0.9% NaCl). The decidua basalis and parietalis were identified retrospectively by the presence of scattered pKRT-positive EVTs in histological sections.
Sex genotyping and histochemistry
The material was sex genotyped by polymerase chain reaction (PCR) for AMELX/AMELY as previously described [20]. The decidua was fixed in 4% paraformaldehyde (PFA) overnight at 4°C, paraffin embedded and sectioned as previously described [20]. For Azan staining, paraffin sections were deparaffinised using xylene and dehydrated by standard procedures. The sections were then treated with 0.1% Azocarmine B (Edward Gurr Ltd., London, UK) in 5% glacial acetic acid (Merck, Darmstadt, Germany) for 3 minutes, rinsed several times in water, treated with 5% phosphotungstic acid (Fluka, Sigma-Aldrich, St. Louis, USA) solution for 6 minutes, again rinsed several times in water and immersed in a 1:1 solution of water to 0.4% orange G (Merck, Darmstadt, Germany)/ 0.2% aniline blue (Nustain, Nottingham, UK) in 1% glacial acetic acid for 15 minutes, all at room temperature (RT). Sections were then rinsed in water, dehydrated through a series of ethanol solutions, xylene and mounted in Entellan (Merck, Darmstadt, Germany).
Immunofluorescence
Paraffin sections were deparaffinised using xylene and dehydrated by standard procedures and used for immunofluorescence as previously described [20]. Briefly, antigen retrieval was performed in citrate buffer, followed by treatment with blocking solution consisting of 1% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, USA) in 0.05% PBST [0.05% Tween-20 (Merck-Schuchardt, Hohenbrunn, Germany) in phosphate-buffered saline (PBS)] for 40 minutes at RT. Sections were then incubated with the primary antibodies diluted in blocking solution for 1 hour at RT, washed twice in PBST for 5 minutes and incubated with secondary antibodies diluted in blocking solution for 1 hour at RT. The primary antibodies used were mouse anti-pan-keratin (pKRT; 1:100; AE1/AE3, Dako, Heverlee, Belgium), rabbit anti-platelet/endothelial adhesion molecule 1 (PECAM1; 1:200; sc1506-R, Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-alpha-smooth muscle actin (ACTA2; 1:200; ab5694, Abcam, Cambridge, UK), mouse anti-podoplanin (PDPN; 1:100; ab77854, Abcam, Cambridge, UK) and rat anti-PDPN (1:100; 12-9381-42, eBioscience, San Diego, CA, USA). The secondary antibodies used were Alexa Fluor 594 donkey anti-mouse IgG (1:500; A-21203), Alexa Fluor 488 goat anti-rabbit IgG (1:500; A-11034), Alexa Fluor 555 goat anti-rat IgG (1:500; A-21434), Alexa Fluor 488 donkey anti-mouse IgG (1:500; A-21202) and Alexa Fluor 647 donkey anti-rabbit IgG (1:500; A-31573) (all from Life Technologies, Eugene, OR, USA). Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories Ltd., Peterborough, UK) and sections were mounted in Prolong Gold anti-fade reagent (Life technologies). As negative controls, slides were immunostained omitting the primary antibodies.
Fluorescence in situ hybridization (FISH) for chrX and chrY
FISH with probes of human chrX and chrY was carried out to distinguish fetal (male) cells from maternal (female) cells. After selected immunostained slides were imaged, they were incubated with 0.4% pepsin (pepsin from porcine gastric mucosa, P7000-100G, Sigma-Aldrich, St Louis, MO, USA) in 0.02M HCl for 5 minutes at 37°C. Centromere specific alphoid repeat probes used were pBamX5 and pDP97 of the human chrX and chrY, respectively [21, 22]. Both probes were labeled by nick translation with FITC (chrX probe) or Cy3 (chrY probe). Probe labeling and hybridization reaction were performed using previously published protocols [23, 24].
Image acquisition
Slides were either scanned on a Pannoramic 250 FLASH digital scanner (3D HISTECH Ltd., Budapest, Hungary) and representative areas selected for images using the software program ‘Pannoramic viewer’ (3D HISTECH Ltd., Budapest, Hungary); or photographed on a Leica DMRA fluorescence microscope (Leica, Wetzlar, Germany) equipped with a CoolSnap HQ2 camera (Photometrics, Tucson, USA). Figures were compiled using Photoshop CS6 (Adobe Systems Inc., San Jose, USA).
Quantification of veins being invaded by EVTs
The combination of Azan staining and immunofluorescence for ACTA2, PECAM1 and PDPN on serial sections from the decidua basalis enabled us to distinguish decidual veins from arteries and lymphatic vessels. Decidual veins were PECAM1-positive, ACTA2-negative and PDPN-negative vessels, with reduced amounts of extracellular matrix surrounding them. Veins were considered invaded when there were one or multiple (male) EVTs (KRT-positive, chrY-positive) penetrating the (maternal) vessel wall (chrY-negative, PECAM1-positive, ACTA2-negative and PDPN-negative). To quantify the percentage of decidual veins invaded by EVTs, we manually counted decidual veins (with and without EVTs invasion) in each paraffin section of decidua basalis of different individuals (N = 9) between W5.5-W12. The number of paraffin sections (n) counted is shown. The results are shown as mean ± standard deviation.
Results
Interstitial mononuclear EVTs invade decidual veins from W5.5-W7.5
We investigated the presence of (male) EVTs in the decidua in the period W5.5-W12 and have analyzed a total of n = 19 samples of decidua basalis and n = 20 decidua parietalis from N = 13 women (S1 Table). Due to a paucity of markers to identify specifically EVTs, we used a combined approach of cytogenetics (FISH for sex chromosomes chrX and chrY) and immunofluorescence for pan-keratin (pKRT) to distinguish maternal glandular epithelial cells from the fetal (male) EVTs in the endometrium (S1 Fig). This staining-combination also allowed us to distinguish decidua parietalis from decidua basalis (S1 Fig). Combining cytochemistry (Azan staining) and immunofluorescence for the arterial-marker ACTA2, the endothelial-marker PECAM1 and the lymphatic-marker PDPN, we were able to differentiate between arteries, veins and lymphatic vessels.
Surprisingly, between W5.5-W7.5 in the decidua basalis, we detected invasion of (non-dilated) ACTA2-negative PECAM1-positive decidual (maternal) veins by (male) individual interstitial mononuclear EVTs (Fig 1A–1E). These (male) EVTs were clearly observed penetrating the endothelial wall of decidual veins, often in consecutive sections (Fig 1B) in all the W5.5-W7.5 decidua basalis analyzed (n = 9 from N = 6 individuals). We counted decidual veins in paraffin sections (n = 40) from different individuals between W5.5-W7.5 (N = 4), and observed that on average 17% (147/856) of the decidual veins were invaded by EVTs (Fig 1E, orange bars).
By contrast, individual interstitial mononuclear EVTs were always observed outside the arterial smooth-muscle layer of the ACTA2-positive PECAM1-positive decidual spiral arteries, even in those arteries located close to the maternal basal plate and in the vicinity of EVTs (Fig 2).
From W8-W12, mononuclear EVTs invade spiral arteries as well as decidual veins
Between W8-W12 (N = 7), interstitial mononuclear EVTs were still observed penetrating many decidual veins both close to the basal plate and more interiorly located (Fig 3A and 3B and S2 Fig). We counted decidual veins in paraffin sections (n = 47) from different individuals between W8.1-W12 (N = 5), and observed that on average 16% (165/1038) of the decidual veins were invaded by EVTs (Fig 1E, blue bars), comparable to what was observed between W5.5-W7.5. At this gestational age, many decidual spiral arteries located at the maternal basal plate were indeed being remodeled and contained endovascular and intramural EVTs in the lumen and tunica media, respectively (Fig 3C). However, we noticed that deeper located decidual spiral arteries remained unremodelled, whereas neighboring deeper located veins were consistently invaded by individual interstitial mononuclear EVTs in all decidua basalis analyzed (Fig 3B and 3C and S2 Fig).
From the decidual samples analyzed in this study, cytogenetic analysis revealed that one individual decidua was from a W8.4 conceptus with Klinefelter syndrome (mosaic 47,XXY and 46,XY) (Fig 4A), even though additional chromosomal abnormalities were not investigated. Importantly, interstitial mononuclear XXY EVTs were observed entering decidual veins (Fig 4A), as in the other decidua of similar age, suggesting that this aspect of the establishment of the materno-fetal interface occurred normally.
Interstitial mononuclear EVTs entered decidual lymphatics from W5.5-W12
To exclude that the PECAM1-positive ACTA2-negative vessels were lymphatic vessels instead of veins, we investigated the expression of PDPN in the decidua [25–27]. Notably, not only PDPN-negative PECAM1-positive decidual veins were being invaded by interstitial mononuclear EVTs, but also many PDPN-positive PECAM1-positive decidual lymphatic vessels were in fact being invaded by interstitial mononuclear EVTs between W5.5-W12 (N = 11 out of 12 analyzed) (Fig 4B). We observed dilated PDPN-positive lymphatics encircling (or insulating) spiral arteries to create characteristic round structures (data not shown), confirming findings by Volchek and colleagues (2010) [27]. The biological significance of these characteristic structures remains to be investigated. We also report PDPN-positive mesenchymal stroma inside the placental villi (cyan arrow in S2 Fig, top right panel), as previously reported by Wang et al (2011) [28].
Aggregates of mononuclear EVTs were present in decidual veins from W5.5
At W5.5, we could already observe small aggregates of mononuclear EVTs in veins in the decidua basalis (Fig 5A). Those resembled syncytial knots, but were morphologically distinct. At later time points, from W7-W12 (N = 6), bona fide syncytial knots (central area of multiple nuclei and large peripheral area of cytoplasm) were often present in dilated veins in both the decidua basalis (Fig 5A and 5B) and parietalis (Fig 5B), suggestive of the gradual establishment of materno-placental vascular connection.
Allo-epi-endothelium in the basal plate of first trimester decidua basalis
Finally, we report that the basal plate of the maternal decidua (between the anchoring villi) was lined by both (male) pKRT-positive EVTs and (female) PECAM1-positive maternal endothelial cells in the period analyzed (W5.5-W12) (Fig 6). This allo-epi-endothelium monolayer organization of ‘epithelial’ EVTs and maternal endothelial cells in a patchy-mosaic fashion has been described in term decidua [5] and we describe it now in the human decidua during the first trimester as well.
Discussion
Interstitial mononuclear EVTs enter the maternal circulation via veins and lymphatics
Our systematic analysis of first trimester decidua using a combination of immunofluorescence and FISH to distinguish between the types of vasculature and identify the EVTs unambiguously allowed us to reveal for the first time the direct invasion by interstitial mononuclear EVTs of decidual veins and lymphatics in the maternal decidua basalis by W5.5. This suggests an efficient entry of interstitial mononuclear EVTs into the maternal (blood and lymph) circulation in the absence of robust materno-placental vascular connection [10–12].
Consistent with our findings, very recently the group of Huppertz has also showed evidence for EVTs invasion of uterine veins [29], using an antibody against human leukocyte antigen (HLA)-G, often used as specific EVT marker [30]. However, caution should be taken when using only HLA-G to identify EVTs, due to the different HLA-G isoforms [31]. In addition, using HLA-G immunostaining as means to identify EVTs, the same group has also reported that EVTs (coined “endoglandular”) also invaded uterine glands [29, 32, 33]. In our study, using a combination of immunofluorescence and FISH, we were unable to detect (male) EVTs in maternal uterine glands between W5.5 and W12.
The timing of the venous invasion process (by the EVTs) is different from the passive deportation of (non-viable) syncytial knots detaching directly from placental villi to the intervillous space and being then transported to the decidual venous lakes once the materno-placental vascular connection has been established [13–15, 34].
Materno-fetal interface: EVTs stepping out of the uterus
The materno-fetal interface encompasses three main processes: the establishment of immune tolerance, regulation of decidual invasion by EVTs and uterine vascular remodeling [35], all taking place primarily in the uterus. Our results are in agreement with the timing of vascular remodeling as well as with the invasion of the decidua by interstitial and endovascular EVTs. Moreover, we observed the formation of the allo-epi-endothelium in the basal plate of the decidua basalis and therefore acknowledge the existence of epithelial EVTs [5].
Here, we propose that when interstitial mononuclear EVTs enter the maternal circulation they are not only substantially enlarging the materno-fetal interface, but they are also doing so earlier than previously accepted [via placental debris after materno-placental vascular connection [18]] and via an alternatively vascular route (decidual lymphatics and veins).
This novel venue of materno-fetal interface (taking place outside the uterus) may contribute significantly to trigger the maternal immune system to perhaps confer recognition to prevent rejection of the fetus while in the uterus. The EVTs have developed several strategies to ensure immune tolerance while in the maternal environment. This includes the expression of HLA-G, instead of HLA-A and HLA-B, in this way avoiding clearance by maternal natural killer cells [36]. In the uterus, the EVTs encounter and crosstalk with uterine macrophages, uterine natural killer cells and T lymphocytes, modulating locally the maternal innate and adaptive immune response [35, 36]. The EVTs that enter the maternal circulation may have a primary role contributing to the adaptive and innate immune response, but through the recruitment of maternal cells to the uterus subsequently also contribute to successful vascular remodeling [4].
Materno-fetal interface and pregnancy complications
Sex chromosomal aneuploidy disorders, including Klinefelter syndrome, often produce small-for-gestational age fetuses [37]. We describe here the decidua basalis of one W8.4 pregnancy with Klinefelter syndrome (mosaic 47,XXY and 46,XY) and show interstitial mononuclear EVTs entering the maternal circulation via decidual veins. We were unable to detect “plugged” of remodeled arteries colonized by endovascular EVTs, probably due to the young age of the fetus.
Our understanding of placental complications in humans is rather limited due to the lack of in vitro assays and suitable animal models. However it is clear that the materno-fetal interface in all its facets is indispensable for a successful pregnancy [38, 39]. We speculate that pregnancy complications such as preeclampsia and intrauterine growth restriction that are closely associated to defects in vascular remodeling [3, 7, 40], as well as recurrent abortion, may correlate with defective presence of EVTs in the maternal circulation.
Supporting Information
Acknowledgments
We would like to thank the Centre for Contraception Sexuality and Abortion (CASA) from Leiden and The Hague for the collection of human fetal material.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The authors received no specific funding for this work.
References
- 1.Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. American journal of obstetrics and gynecology. 2002;187(5):1416–23. [DOI] [PubMed] [Google Scholar]
- 2.Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. The International journal of developmental biology. 2010;54(2–3):269–80. PubMed Central PMCID: PMC2974212. 10.1387/ijdb.082769mk [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension. 2013;62(6):1046–54. 10.1161/HYPERTENSIONAHA.113.01892 [DOI] [PubMed] [Google Scholar]
- 4.Harris LK. Review: Trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta. 2010;31 Suppl:S93–8. [DOI] [PubMed] [Google Scholar]
- 5.Byrne S, Challis E, Williams JL, Pringle JH, Hennessy JM, Ockleford CD. A mosaic cell layer in human pregnancy. Placenta. 2010;31(5):373–9. 10.1016/j.placenta.2010.02.005 [DOI] [PubMed] [Google Scholar]
- 6.Burke SD, Karumanchi SA. Spiral artery remodeling in preeclampsia revisited. Hypertension. 2013;62(6):1013–4. 10.1161/HYPERTENSIONAHA.113.02049 [DOI] [PubMed] [Google Scholar]
- 7.Fisher SJ. Why is placentation abnormal in preeclampsia? American journal of obstetrics and gynecology. 2015;213(4 Suppl):S115–22. PubMed Central PMCID: PMC4592742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Plaisier M, Dennert I, Rost E, Koolwijk P, van Hinsbergh VW, Helmerhorst FM. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. Human reproduction. 2009;24(1):185–97. 10.1093/humrep/den296 [DOI] [PubMed] [Google Scholar]
- 9.Plaisier M, Rodrigues S, Willems F, Koolwijk P, van Hinsbergh VW, Helmerhorst FM. Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues. Fertility and sterility. 2007;88(1):176–87. 10.1016/j.fertnstert.2006.11.102 [DOI] [PubMed] [Google Scholar]
- 10.Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. American journal of obstetrics and gynecology. 1999;181(3):718–24. [DOI] [PubMed] [Google Scholar]
- 11.Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27(9–10):939–58. 10.1016/j.placenta.2005.12.006 [DOI] [PubMed] [Google Scholar]
- 12.Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. The American journal of pathology. 2000;157(6):2111–22. PubMed Central PMCID: PMC1885754. 10.1016/S0002-9440(10)64849-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Craven CM, Ward K. Syncytiotrophoblastic fragments in first-trimester decidual veins: evidence of placental perfusion by the maternal circulation early in pregnancy. American journal of obstetrics and gynecology. 1999;181(2):455–9. [DOI] [PubMed] [Google Scholar]
- 14.Craven CM, Chedwick LR, Ward K. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblast cell invasion. American journal of obstetrics and gynecology. 2002;186(2):291–6. [DOI] [PubMed] [Google Scholar]
- 15.Craven CM, Zhao L, Ward K. Lateral placental growth occurs by trophoblast cell invasion of decidual veins. Placenta. 2000;21(2–3):160–9. 10.1053/plac.1999.0449 [DOI] [PubMed] [Google Scholar]
- 16.Delmis J, Pfeifer D, Ivanisevic M, Forko JI, Hlupic L. Sudden death from trophoblastic embolism in pregnancy. European journal of obstetrics, gynecology, and reproductive biology. 2000;92(2):225–7. [DOI] [PubMed] [Google Scholar]
- 17.Merviel P, Aractingi S, Uzan S. [Detection of fetal cells in maternal blood: myth or reality?]. Gynecologie, obstetrique & fertilite. 2001;29(5):371–6. [DOI] [PubMed] [Google Scholar]
- 18.Chamley LW, Holland OJ, Chen Q, Viall CA, Stone PR, Abumaree M. Review: where is the maternofetal interface? Placenta. 2014;35 Suppl:S74–80. [DOI] [PubMed] [Google Scholar]
- 19.Sarker S, Scholz-Romero K, Perez A, Illanes SE, Mitchell MD, Rice GE, et al. Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. Journal of translational medicine. 2014;12:204 PubMed Central PMCID: PMC4283151. 10.1186/1479-5876-12-204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Heeren A, van Iperen L, Klootwijk DB, de Melo Bernardo A, Roost MS, Gomes Fernandes MM, et al. Development of the follicular basement membrane during human gametogenesis and early folliculogenesis. BMC developmental biology. 2015;15(1):4. PubMed Central PMCID: PMC4307144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cooke HJ, Schmidtke J, Gosden JR. Characterisation of a human Y chromosome repeated sequence and related sequences in higher primates. Chromosoma. 1982;87(5):491–502. [DOI] [PubMed] [Google Scholar]
- 22.Willard HF, Smith KD, Sutherland J. Isolation and characterization of a major tandem repeat family from the human X chromosome. Nucleic acids research. 1983;11(7):2017–33. PubMed Central PMCID: PMC325859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Szuhai K, Bezrookove V, Wiegant J, Vrolijk J, Dirks RW, Rosenberg C, et al. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes, chromosomes & cancer. 2000;28(1):92–7. [DOI] [PubMed] [Google Scholar]
- 24.Szuhai K, Tanke HJ. COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nature protocols. 2006;1(1):264–75. 10.1038/nprot.2006.41 [DOI] [PubMed] [Google Scholar]
- 25.Red-Horse K. Lymphatic vessel dynamics in the uterine wall. Placenta. 2008;29 Suppl A:S55–9. PubMed Central PMCID: PMC2435487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. The Journal of clinical investigation. 2006;116(10):2643–52. PubMed Central PMCID: PMC1570373. 10.1172/JCI27306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Volchek M, Girling JE, Lash GE, Cann L, Kumar B, Robson SC, et al. Lymphatics in the human endometrium disappear during decidualization. Human reproduction. 2010;25(10):2455–64. 10.1093/humrep/deq224 [DOI] [PubMed] [Google Scholar]
- 28.Wang Y, Sun J, Gu Y, Zhao S, Groome LJ, Alexander JS. D2-40/podoplanin expression in the human placenta. Placenta. 2011;32(1):27–32. PubMed Central PMCID: PMC3062260. 10.1016/j.placenta.2010.10.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Moser G, Weiss G, Sundl M, Gauster M, Siwetz M, Lang-Olip I, et al. Extravillous trophoblasts invade more than uterine arteries: evidence for the invasion of uterine veins. Histochem Cell Biol. 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends in immunology. 2008;29(7):313–21. 10.1016/j.it.2008.02.012 [DOI] [PubMed] [Google Scholar]
- 31.James JL, Chamley LW. A caution on the use of HLA-G isoforms as markers of extravillous trophoblasts. Placenta. 2008;29(3):305–6; author reply 7. 10.1016/j.placenta.2007.12.004 [DOI] [PubMed] [Google Scholar]
- 32.Moser G, Weiss G, Gauster M, Sundl M, Huppertz B. Evidence from the very beginning: endoglandular trophoblasts penetrate and replace uterine glands in situ and in vitro. Human reproduction. 2015;30(12):2747–57. PubMed Central PMCID: PMC4719185. 10.1093/humrep/dev266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Moser G, Gauster M, Orendi K, Glasner A, Theuerkauf R, Huppertz B. Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Human reproduction. 2010;25(5):1127–36. 10.1093/humrep/deq035 [DOI] [PubMed] [Google Scholar]
- 34.Chamley LW, Chen Q, Ding J, Stone PR, Abumaree M. Trophoblast deportation: just a waste disposal system or antigen sharing? Journal of reproductive immunology. 2011;88(2):99–105. 10.1016/j.jri.2011.01.002 [DOI] [PubMed] [Google Scholar]
- 35.Lash GE. Molecular Cross-Talk at the Feto-Maternal Interface. Cold Spring Harbor perspectives in medicine. 2015;5(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gregori S, Amodio G, Quattrone F, Panina-Bordignon P. HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche. Frontiers in immunology. 2015;6:128 PubMed Central PMCID: PMC4378286. 10.3389/fimmu.2015.00128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Oelberg DG. Consultation with the specialist: prenatal growth: the sum of maternal, placental, and fetal contributions. Pediatrics in review / American Academy of Pediatrics. 2006;27(6):224–9. [DOI] [PubMed] [Google Scholar]
- 38.Redman CW, Tannetta DS, Dragovic RA, Gardiner C, Southcombe JH, Collett GP, et al. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta. 2012;33 Suppl:S48–54. [DOI] [PubMed] [Google Scholar]
- 39.Southcombe J, Redman C, Sargent I. Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. Journal of reproductive immunology. 2010;87(1–2):52–9. PubMed Central PMCID: PMC2995212. 10.1016/j.jri.2010.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biology of reproduction. 2003;69(1):1–7. 10.1095/biolreprod.102.014977 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.